c ebpβ-lip drug A screening strategy for the discovery of drugs that reduce C/EBPβ-LIP translation with potential calorie restriction mimetic properties C/EBPβ-LIP induces cancer-type metabolic reprogramming
C EBP LIP induces cancer type metabolic reprogramming by regulating the let 7 LIN28B circuit in mice Communications Biology C EBP LIP mediated activation of the malate aspartate shuttle sensitizes cells to glycolysis inhibition ScienceDirect Frontiers C EBP as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications Frontiers Emerging functions of C EBP in breast cancer
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20



